News
HC Wainwright & Co. Maintains Buy on Coherus BioSciences, Lowers Price Target to $11
20 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Coherus BioSciences, Maintains $13 Price Target
14 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Recap: Coherus BioSciences Q4 Earnings
13 Mar 24
Earnings
Coherus BioSciences Q4 2023 Adj EPS $(0.62) Misses $(0.12) Estimate, Sales $91.524M Miss $96.400M Estimate
13 Mar 24
Earnings, Earnings Misses, News
Earnings Scheduled For March 13, 2024
13 Mar 24
Earnings
Earnings Preview For Coherus BioSciences
12 Mar 24
Earnings
Coherus Launches UDENYCA ONBODY For Pegfilgrastim-cbqv
21 Feb 24
Biotech, News, General
Baird Maintains Outperform on Coherus BioSciences, Lowers Price Target to $9
23 Jan 24
News, Price Target, Analyst Ratings
Truist Securities Maintains Buy on Coherus BioSciences, Lowers Price Target to $8-Report Released on 22 January 2024
23 Jan 24
News, Price Target, Analyst Ratings
Truist Securities Maintains Buy on Coherus BioSciences, Lowers Price Target to $8
23 Jan 24
News, Price Target, Analyst Ratings
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
22 Jan 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today?
22 Jan 24
Biotech, Equities, M&A, News, Health Care, Asset Sales, Movers, Trading Ideas, General
Market-Moving News for January 22nd
22 Jan 24
Movers, Trading Ideas
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
22 Jan 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
CORRECTION: Coherus To Divest Ophthalmology Franchise To Sandoz In $170M Cash Deal
22 Jan 24
M&A, News
Coherus Earlier Announced Agreement To Divest Ophthalmology Franchise Cimerli To Novarts' Sandoz Unit For $170M Upfront All Cash Deal
22 Jan 24
M&A, News
Coherus To Divest Ophthalmology Franchise To Sandoz In $170M Cash Deal
22 Jan 24
M&A, News
12 Health Care Stocks Moving In Friday's Pre-Market Session
19 Jan 24
Movers
12 Health Care Stocks Moving In Thursday's After-Market Session
18 Jan 24
Movers
Coherus Presents Phase 2 Clinical Data On Casdozokitug, A First-in-Class IL-27-Targeted Antibody, At The 2024 ASCO GI Cancers Symposium; The Primary Endpoint Of The Lead-in Portion Of The Study Was Safety And Tolerability
18 Jan 24
Biotech, News, General
Press releases
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
13 Mar 24
Earnings, News, Press Releases
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
5 Mar 24
News, Press Releases
Coherus Completes Divestiture of Ophthalmology Franchise
4 Mar 24
News, Contracts, Press Releases
Coherus BioSciences Announces New Employment Inducement Grants
23 Feb 24
Press Releases
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in $170 Million Upfront All Cash Deal
22 Jan 24
News, Financing, Press Releases
Thinking about buying stock in YanGuFang International, Broadcom, Applied Digital, Intelligent Bio Solutions, or Coherus Biosciences?
19 Jan 24
Small Cap, Opinion, Press Releases
Coherus Presents Positive Phase 2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2024 ASCO GI Cancers Symposium
18 Jan 24
Press Releases
INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)
4 Jan 24
News, Contracts, Press Releases
Coherus Announces U.S. Launch of LOQTORZI™
2 Jan 24
Health Care, Press Releases